SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-13-000994
Filing Date
2013-03-14
Accepted
2013-03-14 08:15:32
Documents
18
Period of Report
2013-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_031413.htm 8-K 26325
2 EXHIBIT 99.1 exh_991.htm EX-99.1 86896
3 EXHIBIT 99.2 exh_992.htm EX-99.2 14079
4 exh9921.jpg GRAPHIC 105551
5 exh9922.jpg GRAPHIC 210565
6 exh9923.jpg GRAPHIC 162613
7 exh9924.jpg GRAPHIC 132258
8 exh9925.jpg GRAPHIC 215808
9 exh9926.jpg GRAPHIC 136089
10 exh9927.jpg GRAPHIC 175385
11 exh9928.jpg GRAPHIC 134810
12 exh9929.jpg GRAPHIC 185669
13 exh99210.jpg GRAPHIC 183901
14 exh99211.jpg GRAPHIC 207973
15 exh99212.jpg GRAPHIC 208696
16 exh99213.jpg GRAPHIC 194507
17 exh99214.jpg GRAPHIC 160021
18 exh99215.jpg GRAPHIC 122123
  Complete submission text file 0001171843-13-000994.txt   3624354
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33560 | Film No.: 13689144
SIC: 2834 Pharmaceutical Preparations